Home > Insider Trading > Filing (0001231552-10-000005)

Filing Details

Accession Number:: 0001231552-10-000005
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-08-11 13:00:00
Reporting Period:: 2010-06-01

Filing Date:: 2010-08-11
Accepted Time:: 2010-08-11 14:25:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1054833	Coventry Health Care Inc	CVH	Hospital & Medical Service Plans (6324)	522073000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1231552	Jr C Harvey Demovick	6705 Rockledge Drive Suite 900 Bethesda MD 20817	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-06-01	290	$0.00	959,199	No	4	A	Direct
Common Stock Restricted	Disposition	2010-08-09	19,000	$21.75	940,199	No	4	S	Direct
Common Stock Restricted	Disposition	2010-08-09	19,984	$21.75	920,215	No	4	S	Direct
Common Stock Restricted	Disposition	2010-08-09	17,700	$21.64	902,515	No	4	S	Direct
Common Stock Restricted	Disposition	2010-08-09	1,300	$21.60	901,215	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares acquired in 401(k) Plan through employer matching contributions from March 8, 2010 through June 1, 2010,
Shares were acquired at various prices at market value through regular employer matching contributions.
Includes the following: Table I-Non-Derivative Securities consisting of 4,374 shares of common stock held directly, 290 shares of common stock held indirectly by managed account (401(k) Plan, and 264,880 shares of restricted common stock with restrictions lapsed or lapsing in equal annual increments over a three-year period; and Table II-Derivative Securities consisting of a non-qualified stock option for 689,655 shares of common stock vested or vesting in equal annual increments over a three-year period, held directly.
See Footnote 3 for shares held directly and indirectly.
Restrictions released on shares sold.
Includes the following: Table I-Non-Derivative Securities consisting of 4,374 shares of common stock held directly, 290 shares of common stock held indirectly by managed account (401(k) Plan, and 245,880 shares of restricted common stock with restrictions lapsed or lapsing in equal annual increments over a three-year period; and Table II-Derivative Securities consisting of a non-qualified stock option for 689,655 shares of common stock vested or vesting in equal annual increments over a three-year period, held directly.
See Footnote 6 for shares held directly and indirectly.
Restrictions released on shares sold.
Includes the following: Table I-Non-Derivative Securities consisting of 4,374 shares of common stock held directly, 290 shares of common stock held indirectly by managed account (401(k) Plan, and 225,896 shares of restricted common stock with restrictions lapsed or lapsing in equal annual increments over a three-year period; and Table II-Derivative Securities consisting of a non-qualified stock option for 689,655 shares of common stock vested or vesting in equal annual increments over a three-year period, held directly.
See Footnote 9 for shares held directly and indirectly.
Restrictions released on shares sold.
Includes the following: Table I-Non-Derivative Securities consisting of 4,374 shares of common stock held directly, 290 shares of common stock held indirectly by managed account (401(k) Plan, and 208,196 shares of restricted common stock with restrictions lapsed or lapsing in equal annual increments over a three-year period; and Table II-Derivative Securities consisting of a non-qualified stock option for 689,655 shares of common stock vested or vesting in equal annual increments over a three-year period, held directly.
See Footnote 12 for shares held directly and indirectly.
Restrictions released on shares sold.
Includes the following: Table I-Non-Derivative Securities consisting of 4,374 shares of common stock held directly, 290 shares of common stock held indirectly by managed account (401(k) Plan, and 206,896 shares of restricted common stock with restrictions lapsed or lapsing in equal annual increments over a three-year period; and Table II-Derivative Securities consisting of a non-qualified stock option for 689,655 shares of common stock vested or vesting in equal annual increments over a three-year period, held directly.
See Footnote 15 for shares held directly and indirectly.